Nephris
1 known investors
Find your way into Nephris
Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease. It focuses on research and innovation for patients with diabetic renal disease.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeed FinancingApr 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nephris do?
- Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease. It focuses on research and innovation for patients with diabetic renal disease.
- Who are Nephris's investors?
- Nephris's investors include Sofinnova Partners.